Clinical trial
An Exploratory Study of FE999908 in Patients With Hepatorenal Syndrome Type 1
NCT01373606 is registered in ClinicalTrials.gov with Ferring Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Study of FE999908 in Patients With Hepatorenal Syndrome Type 1
- Lead sponsor
- Ferring Pharmaceuticals
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- November 30, 2007
- Completion date
- December 31, 2009
- Enrollment
- 8 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hepatorenal syndrome type 1